Cambridge, Mass.-based Sesen Bio, formerly known as Eleven Biotherapeutics Inc., said it raised net proceeds of about $41.9 million via an offering of common shares.
The healthcare company sold 22,222,223 shares, plus a further 3,333,333 stock to the offering's underwriters, at $1.80 apiece.
The offering closed June 4, with Jefferies LLC and Canaccord Genuity LLC acting as representatives of underwriters.
